MANTA Ultrasound Closure Study

NATerminatedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

August 9, 2022

Primary Completion Date

January 11, 2023

Study Completion Date

January 11, 2023

Conditions
Femoral Arteriotomy Closure
Interventions
DEVICE

MANTA Vascular Closure Device

Evaluate the safety of ultrasound guided deployment of MANTA VCD.

Trial Locations (6)

14203

University of Buffalo, Buffalo

20010

Washington Hospital Center, Washington D.C.

22191

Sentara Northern Virginia Medical Center, Woodbridge

48202

Henry Ford, Detroit

78665

Baylor Scott & White, Round Rock

Unknown

Vancouver General Health, Vancouver

Sponsors
All Listed Sponsors
collaborator

Teleflex

INDUSTRY

lead

Essential Medical, Inc.

INDUSTRY

NCT05142566 - MANTA Ultrasound Closure Study | Biotech Hunter | Biotech Hunter